Global Electronic Health Record Market Set To Grow To $14.7bn By 2022

07 August 2018
Pharma

Visiongain’ has launched a new pharma report Electronic Health Record Market Report : On-premise based EHR, Web-based EHR, Cloud-based EHR, Hospitals, Ambulatory Care Centres, Home Healthcare Agencies, Nursing Homes, Assisted Living Facilities, Diagnostic and Imaging Centres, Pharmacies

Electronic health records are the compilation of medical history and family medical history, which has information about a patient’s lifestyle, physical examination and laboratory results, medications prescribed, and other risk factors. Electronic health record includes the creation, development, design, and maintenance of information systems for the healthcare industry.

The electronic health record market has piqued the interest of healthcare IT companies because of its rising demand. The growth in these solutions is mainly because they offer a very cost effective, convenient, as well as better & enhanced healthcare service. The key players of the world electronic health record market are employing novel concepts and ideas, improving manufacturing techniques, and improving the current set of products, besides enhancing their profitability to gain a competitive edge over other market players.

The lead analyst of the report commented “The market for electronic health record is driven by increasing demand for quality healthcare services and solutions, increasing acceptance of mHealth and telehealth practices, demand for improved patient safety and patient care, and increasing government initiatives to promote electronic health record.

However, safeguarding the confidential information related to patients or healthcare organizations is the biggest challenge for the companies involved in this market, thus data security & privacy concerns are restraining the market growth.”

Leading companies featured in the report include McKesson Corporation, Allscripts Healthcare Solutions, Inc., athenahealth, Inc., Epic Systems Corporation, GE Healthcare, Cerner Corporation, Oracle Corporation, Philips and Infor, Inc.

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

Read

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

Read

Visiongain Publishes Biological Imaging Reagents Market Report 2021-2031

Increasing prevalence of cardiovascular diseases is increasing demand of biological imaging reagents for the diagnosis and treatment of cardiovascular diseases due to this reason increasing prevalence of cardiovascular diseases is acting as a driver for biological imaging reagent market.

13 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever